Johnson & Johnson (1JNJ) Stock Forecast & Price Target

Compare

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1JNJ Analyst Ratings

Moderate Buy

9 Buy

8 Hold

0 Sell

Based on 17 analysts giving stock ratings to

Johnson

& Johnson

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1JNJ Stock 12 Month Forecast

Average Price Target

€156.50

▲(2.24% Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Johnson & Johnson in the last 3 months. The average price target is €156.50 with a high forecast of €175.72 and a low forecast of €140.75. The average price target represents a 2.24% change from the last price of €153.08.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"131":"€131","176":"€176","142.25":"€142.3","153.5":"€153.5","164.75":"€164.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":175.72218798,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€175.72</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":156.5036399451,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€156.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":140.74835445,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€140.75</span>\n  </div></div>","useHTML":true}}],"tickPositions":[131,142.25,153.5,164.75,176],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,152.24,154.0463221523077,155.85264430461538,157.65896645692308,159.46528860923078,161.27161076153845,163.07793291384615,164.88425506615386,166.69057721846156,168.49689937076923,170.30322152307693,172.10954367538463,173.9158658276923,{"y":175.72218798,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,152.24,152.56797230346925,152.89594460693846,153.2239169104077,153.55188921387693,153.87986151734614,154.20783382081538,154.53580612428462,154.86377842775386,155.19175073122307,155.5197230346923,155.84769533816154,156.17566764163075,{"y":156.5036399451,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,152.24,151.35602726538463,150.47205453076924,149.58808179615386,148.70410906153847,147.8201363269231,146.9361635923077,146.0521908576923,145.1682181230769,144.28424538846153,143.40027265384614,142.51629991923076,141.63232718461538,{"y":140.74835445,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":145.103,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":141.945,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.553,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.983,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.714,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.968,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":154.489,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.66,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.51,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.823,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.393,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.095,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":152.24,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€175.72

Average Price Target€156.50

Lowest Price Target€140.75

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Vamil Divan

Guggenheim

€143.12→€176.55

Buy

15.33%

Upside

Upgraded

09/22/25

Johnson & Johnson upgraded to Buy from Neutral at GuggenheimJohnson & Johnson upgraded to Buy from Neutral at Guggenheim

Asad Haider

Goldman Sachs

€158.55→€159.41

Buy

4.13%

Upside

Reiterated

09/19/25

Goldman Sachs Keeps Their Buy Rating on Johnson & Johnson (JNJ)

Matt Miksic

Barclays

€150.84

Hold

-1.47%

Downside

Reiterated

09/18/25

Johnson & Johnson (JNJ) Gets a Hold from Barclays

Chris Schott

J.P. Morgan

€158.55→€171.41

Hold

11.97%

Upside

Reiterated

09/16/25

J.P. Morgan Sticks to Their Hold Rating for Johnson & Johnson (JNJ)

Veda Pharmyne

TR | OpenAI - 4o

€164.55→€175.69

Buy

14.77%

Upside

Reiterated

09/09/25

AI Generated ArticleAI Generated Article

Larry Biegelsen

Wells Fargo

€145.7

Hold

-4.82%

Downside

Reiterated

09/04/25

Balanced Outlook on Johnson & Johnson's MedTech Growth Amid Competitive Challenges

Alexandria Hammond

Wolfe Research

€149.98→€167.12

Buy

9.17%

Upside

Reiterated

09/03/25

Wolfe Research Sticks to Their Buy Rating for Johnson & Johnson (JNJ)

Joanne Wuensch

Citi

€158.55→€171.41

Buy

11.97%

Upside

Reiterated

08/21/25

Johnson & Johnson price target raised to $200 from $185 at CitiJohnson & Johnson price target raised to $200 from $185 at Citi

Hans Engel

Erste Group

―

Buy

―

Upgraded

07/23/25

Johnson & Johnson upgraded to Buy from Hold at Erste GroupJohnson & Johnson upgraded to Buy from Hold at Erste Group

David Risinger

Leerink Partners

€131.13→€146.55

Hold

-4.26%

Downside

Reiterated

07/18/25

Balanced Outlook for Johnson & Johnson Amid Growth Prospects and Legal Uncertainties

Tim Anderson

Bank of America Securities

€137.98→€149.98

Hold

-2.02%

Downside

Reiterated

07/17/25

Johnson & Johnson: Hold Rating Amid Mixed Signals and Uncertainties

Terence Flynn

Morgan Stanley

€146.55→€150.84

Hold

-1.47%

Downside

Reiterated

07/17/25

Johnson & Johnson: Balancing Strong Growth Projections with Uncertainties - Hold Rating Maintained

Lee Hambright

Bernstein

€136.27→€147.41

Hold

-3.70%

Downside

Reiterated

07/17/25

Johnson & Johnson price target raised to $172 from $159 at BernsteinJohnson & Johnson price target raised to $172 from $159 at Bernstein

Danielle Antalffy

UBS

€154.27→€162.84

Buy

6.37%

Upside

Reiterated

07/17/25

Johnson & Johnson price target raised to $190 from $180 at UBSJohnson & Johnson price target raised to $190 from $180 at UBS

David Toung

Argus Research

―

Buy

―

Reiterated

07/16/25

Argus Research Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Vamil Divan

Guggenheim

€143.12→€176.55

Buy

15.33%

Upside

Upgraded

09/22/25

Johnson & Johnson upgraded to Buy from Neutral at GuggenheimJohnson & Johnson upgraded to Buy from Neutral at Guggenheim

Asad Haider

Goldman Sachs

€158.55→€159.41

Buy

4.13%

Upside

Reiterated

09/19/25

Goldman Sachs Keeps Their Buy Rating on Johnson & Johnson (JNJ)

Matt Miksic

Barclays

€150.84

Hold

-1.47%

Downside

Reiterated

09/18/25

Johnson & Johnson (JNJ) Gets a Hold from Barclays

Chris Schott

J.P. Morgan

€158.55→€171.41

Hold

11.97%

Upside

Reiterated

09/16/25

J.P. Morgan Sticks to Their Hold Rating for Johnson & Johnson (JNJ)

Veda Pharmyne

TR | OpenAI - 4o

€164.55→€175.69

Buy

14.77%

Upside

Reiterated

09/09/25

AI Generated ArticleAI Generated Article

Larry Biegelsen

Wells Fargo

€145.7

Hold

-4.82%

Downside

Reiterated

09/04/25

Balanced Outlook on Johnson & Johnson's MedTech Growth Amid Competitive Challenges

Alexandria Hammond

Wolfe Research

€149.98→€167.12

Buy

9.17%

Upside

Reiterated

09/03/25

Wolfe Research Sticks to Their Buy Rating for Johnson & Johnson (JNJ)

Joanne Wuensch

Citi

€158.55→€171.41

Buy

11.97%

Upside

Reiterated

08/21/25

Johnson & Johnson price target raised to $200 from $185 at CitiJohnson & Johnson price target raised to $200 from $185 at Citi

Hans Engel

Erste Group

―

Buy

―

Upgraded

07/23/25

Johnson & Johnson upgraded to Buy from Hold at Erste GroupJohnson & Johnson upgraded to Buy from Hold at Erste Group

David Risinger

Leerink Partners

€131.13→€146.55

Hold

-4.26%

Downside

Reiterated

07/18/25

Balanced Outlook for Johnson & Johnson Amid Growth Prospects and Legal Uncertainties

Tim Anderson

Bank of America Securities

€137.98→€149.98

Hold

-2.02%

Downside

Reiterated

07/17/25

Johnson & Johnson: Hold Rating Amid Mixed Signals and Uncertainties

Terence Flynn

Morgan Stanley

€146.55→€150.84

Hold

-1.47%

Downside

Reiterated

07/17/25

Johnson & Johnson: Balancing Strong Growth Projections with Uncertainties - Hold Rating Maintained

Lee Hambright

Bernstein

€136.27→€147.41

Hold

-3.70%

Downside

Reiterated

07/17/25

Johnson & Johnson price target raised to $172 from $159 at BernsteinJohnson & Johnson price target raised to $172 from $159 at Bernstein

Danielle Antalffy

UBS

€154.27→€162.84

Buy

6.37%

Upside

Reiterated

07/17/25

Johnson & Johnson price target raised to $190 from $180 at UBSJohnson & Johnson price target raised to $190 from $180 at UBS

David Toung

Argus Research

―

Buy

―

Reiterated

07/16/25

Argus Research Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Johnson & Johnson

1 Month

xxx

Success Rate

15/25 ratings generated profit

Average Return

+1.28%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +1.28% per trade.

3 Months

xxx

Success Rate

22/25 ratings generated profit

Average Return

+4.21%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 88.00% of your transactions generating a profit, with an average return of +4.21% per trade.

1 Year

Danielle AntalffyUBS

Success Rate

25/25 ratings generated profit

Average Return

+9.70%

reiterated a buy rating 2 months ago

Copying Danielle Antalffy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.70% per trade.

2 Years

xxx

Success Rate

20/20 ratings generated profit

Average Return

+16.93%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +16.93% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1JNJ Analyst Recommendation Trends

Rating

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1JNJ has received 18 Buy Ratings, 20 Hold Ratings, and 0 Sell Ratings. 1JNJ average Analyst price target in the past 3 months is 156.50.

Each month's total comprises the sum of three months' worth of ratings.

1JNJ Financial Forecast

1JNJ Earnings Forecast

Next quarter’s earnings estimate for 1JNJ is €2.33 with a range of €2.22 to €2.45. The previous quarter’s EPS was €2.34. 1JNJ beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 1JNJ has Outperformed its overall industry.

1JNJ Sales Forecast

Next quarter’s sales forecast for 1JNJ is €20.09B with a range of €19.95B to €20.17B. The previous quarter’s sales results were €20.09B. 1JNJ beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 1JNJ has Outperformed its overall industry.

1JNJ Stock Forecast FAQ

What is IT:1JNJ’s average 12-month price target, according to analysts?

Based on analyst ratings, Johnson & Johnson’s 12-month average price target is 156.50.

What is IT:1JNJ’s upside potential, based on the analysts’ average price target?

Johnson & Johnson has 2.24% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Johnson & Johnson a Buy, Sell or Hold?

Johnson & Johnson has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 8 hold ratings and 0 sell ratings.

What is Johnson & Johnson’s share price target?

The average share price target for Johnson & Johnson is 156.50. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €175.72 ,and the lowest forecast is €140.75. The average share price target represents 2.24% Increase from the current price of €153.08.

What do analysts say about Johnson & Johnson?

Johnson & Johnson’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of Johnson & Johnson?

To buy shares of IT:1JNJ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Johnson & Johnson (1JNJ) Stock Forecast & Price Target

1JNJ Analyst Ratings

1JNJ Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Johnson & Johnson

1JNJ Analyst Recommendation Trends

1JNJ Financial Forecast

1JNJ Earnings Forecast

1JNJ Sales Forecast

1JNJ Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts